[Federal Register Volume 61, Number 248 (Tuesday, December 24, 1996)]
[Notices]
[Page 67851]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-32609]


-----------------------------------------------------------------------


DEPARTMENT OF JUSTICE

Manufacturer of Controlled Substance; Notice of Registration

    By Notice dated August 21, 1996, and published in the Federal 
Register on August 30, 1996, (61 FR 45986), Celgene Corporation, 7 
Powder Horn Drive, Warren, New Jersey 07059, made application by 
renewal to the Drug Enforcement Administration (DEA) to be registered 
as a bulk manufacturer of the basic classes of controlled substances 
listed below:

------------------------------------------------------------------------
                    Drug                               Schedule         
------------------------------------------------------------------------
2,5-Dimethoxyamphetamine (7396)............  I                          
Amphetamine (1100).........................  II                         
------------------------------------------------------------------------

    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, Section 823(a) and 
determined that the registration of Celgene Corporation to manufacture 
the listed controlled substances is consistent with the public interest 
at this time. Therefore, pursuant to 21 U.S.C. 823 and 28 C.F.R. 0.100 
and 0.104, the Deputy Assistant Administrator, Office of Diversion 
Control, hereby orders that the application submitted by the above firm 
for registration as a bulk manufacturer of the basic classes of 
controlled substances listed above is granted.

    Dated: November 19, 1996.
Gene R. Haislip,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 96-32609 Filed 12-23-96; 8:45 am]
BILLING CODE 4410-09-M